Fig. 1.Important considerations for managing chronic disease during and following the COVID-19 (SARS-CoV-2) pandemic include: (i) cardiometabolic health complications (e.g., what are the long-term impacts to vascular health?); (ii) lifestyle behaviors (e.g., will COVID-19 affect long-term lifestyle behavioral patterns?); (iii) the health gap (e.g., will COVID-19 widen the gap for underserved populations?); (iv) healthcare adaptations (e.g., what adaptations should be made to clinical practices?); (v) economic (e.g., will COVID-19 affect direct and indirect healthcare costs?); and (vi) the need for data (e.g., what data is being collected to help better understand the long-term cardiometabolic consequences of COVID-19 infection?).